Efficacy and Safety of L-asparaginase Encapsulated in RBC Combined With Gemcitabine or FOLFOX in 2nd Line for Progressive Metastatic Pancreatic Carcinoma

NCT02195180 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

141

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Adenocarcinoma Metastatic

Interventions

DRUG: ERY001
DRUG: Gemcitabine
DRUG: 5-fluoro-uracil/oxaliplatin/leucovorin (folfox)

Sponsor

ERYtech Pharma